Charles Farkas - 29 May 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Charles Farkas by Power of Attorney
Issuer symbol
CNMD
Transactions as of
29 May 2025
Transactions value $
-$29
Form type
4
Filing time
30 May 2025, 17:12:08 UTC
Previous filing
06 May 2025
Next filing
04 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Farkas Charles Director C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO /s/ Thomas Fistek for Charles Farkas by Power of Attorney 30 May 2025 0001615538

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $55.7K +1K +6.12% $55.70 17.3K 29 May 2025 Direct
transaction CNMD Common Stock Tax liability -$55.7K -966 -5.57% $57.69 16.4K 29 May 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD SARs (Stock Appreciation Rights) Options Exercise $0 -1K -100% $0.00 0 29 May 2025 Common Stock 1K $55.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights ("SARs") were granted under the Company's 2007 Non-Employee Director Equity Compensation Plan, with the SARs generally vesting 100% after a one year period.